We draw a baseline first (IGF-1, CBC, inflammatory markers, and a hormone panel depending on the stack), then build the protocol around what we find
In AL amyloidosis, a stepwise approach is recommended, beginning with antimotility agents such as loperamide (up to 32 mg daily), codeine (up to 30 mg twice daily), and diphenoxylate [73, 97]
Duration of treatment may be related to improvement as metformin improves AN and IR if given for 6 months or more [Figure 7a and b].[23] Metformin reduces glucose production by increasing peripheral insulin responsiveness, reduces hyperinsulinemia, body weight and fat mass and improves insulin sensitivity.[30,32,33] The combined use of metformin and TZDs which increase sensitivity to insulin in peripheral muscles, also give good results.[34] The combined metformin and glimepiride (at low dose) is superior in the management of IR studied through HOMA with reduction in HOMA-IR.[35] Metformin is known to improve cardiopulmonary performance in patients with high HOMA-IR possibly by favorable effects on endothelial dysfunction.[18] Cosmetic treatment Because darkening of affected areas is common in AN, Alan Rosenbach considered the possibility that long-pulsed alexandrite laser, which was designed to target melanin in hair could improve this condition
In the body leucovorin is a biologically active form of folate that exists naturally in food sources, as opposed to folic acid, which is a synthetic form
